ZA202106718B - Novel selection marker-comprising cell line and uses thereof for protein production - Google Patents

Novel selection marker-comprising cell line and uses thereof for protein production

Info

Publication number
ZA202106718B
ZA202106718B ZA2021/06718A ZA202106718A ZA202106718B ZA 202106718 B ZA202106718 B ZA 202106718B ZA 2021/06718 A ZA2021/06718 A ZA 2021/06718A ZA 202106718 A ZA202106718 A ZA 202106718A ZA 202106718 B ZA202106718 B ZA 202106718B
Authority
ZA
South Africa
Prior art keywords
cell line
selection marker
protein production
novel selection
novel
Prior art date
Application number
ZA2021/06718A
Other languages
English (en)
Inventor
Bruno Louis Dumas
Mohammed Nabil Lounis
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Publication of ZA202106718B publication Critical patent/ZA202106718B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/102—Mutagenizing nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/001—Oxidoreductases (1.) acting on the CH-CH group of donors (1.3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/20—Type of nucleic acid involving clustered regularly interspaced short palindromic repeats [CRISPR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y103/00—Oxidoreductases acting on the CH-CH group of donors (1.3)
    • C12Y103/05—Oxidoreductases acting on the CH-CH group of donors (1.3) with a quinone or related compound as acceptor (1.3.5)
    • C12Y103/05002—Dihydroorotate dehydrogenase (1.3.5.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Mycology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
ZA2021/06718A 2019-03-19 2021-09-10 Novel selection marker-comprising cell line and uses thereof for protein production ZA202106718B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP19305331 2019-03-19
PCT/EP2020/057583 WO2020188021A1 (en) 2019-03-19 2020-03-19 Novel selection marker-comprising cell line and uses thereof for protein production

Publications (1)

Publication Number Publication Date
ZA202106718B true ZA202106718B (en) 2023-04-26

Family

ID=66001151

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2021/06718A ZA202106718B (en) 2019-03-19 2021-09-10 Novel selection marker-comprising cell line and uses thereof for protein production

Country Status (14)

Country Link
US (1) US12529071B2 (cg-RX-API-DMAC7.html)
EP (1) EP3942054A1 (cg-RX-API-DMAC7.html)
JP (1) JP7609795B2 (cg-RX-API-DMAC7.html)
KR (1) KR102976749B1 (cg-RX-API-DMAC7.html)
CN (1) CN113811615B (cg-RX-API-DMAC7.html)
AU (1) AU2020242966B2 (cg-RX-API-DMAC7.html)
BR (1) BR112021018124A2 (cg-RX-API-DMAC7.html)
CA (1) CA3134116A1 (cg-RX-API-DMAC7.html)
IL (1) IL286419A (cg-RX-API-DMAC7.html)
MX (1) MX2021011303A (cg-RX-API-DMAC7.html)
SG (1) SG11202110105UA (cg-RX-API-DMAC7.html)
TW (1) TWI881970B (cg-RX-API-DMAC7.html)
WO (1) WO2020188021A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA202106718B (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI912369B (zh) * 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8717430D0 (en) 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product
KR100267720B1 (ko) 1997-12-29 2001-03-02 박호군 사람 글루타민 합성효소 유전자를 포함하는 발현벡터 및 이를 이용하여 동물세포에서 에리트로포이에틴을 고수율로 생산하는 방법
US20030166201A1 (en) * 2001-04-30 2003-09-04 Jensen Michael C. Selection systems for genetically modified cells
EP2022855B1 (en) 2006-05-16 2015-08-19 Daiichi Sankyo Company, Limited High secretion production method of protein
WO2012027533A1 (en) * 2010-08-25 2012-03-01 Gt Life Sciences, Inc. Selectable markers and related methods
RU2556816C1 (ru) 2014-03-12 2015-07-20 Открытое акционерное общество "Фармацевтический импорт, экспорт" (ОАО "Фармимэкс") Штамм клеток яичников китайского хомячка - продуцент рекомбинантного антитела против фактора некроза опухоли альфа человека
CA2965202C (en) * 2014-10-23 2023-02-28 Sanofi Novel selection marker for cell transfection and protein production
EP3344243B1 (en) * 2015-09-01 2020-12-09 The Broad Institute, Inc. Compounds and methods useful for treating or preventing hematological cancers
WO2017117006A1 (en) * 2015-12-29 2017-07-06 The Board Of Trustees Of The Leland Stanford Junior University Use of a dhodh inhibitor in combination with an inhibitor of pyrimidine salvage
CN109777837A (zh) 2018-12-26 2019-05-21 首都医科大学 一种利用CRISPR/Cas9系统构建致死基因全身性敲除小鼠模型的方法
TWI912369B (zh) 2020-09-21 2026-01-21 法商賽諾菲公司 用於生產治療蛋白之高生產重組中國倉鼠卵巢細胞株之世代

Also Published As

Publication number Publication date
MX2021011303A (es) 2021-10-22
CN113811615B (zh) 2025-11-11
CA3134116A1 (en) 2020-09-24
IL286419A (en) 2021-10-31
AU2020242966A1 (en) 2021-10-21
US12529071B2 (en) 2026-01-20
BR112021018124A2 (pt) 2021-11-16
AU2020242966B2 (en) 2025-09-25
US20220177909A1 (en) 2022-06-09
JP7609795B2 (ja) 2025-01-07
EP3942054A1 (en) 2022-01-26
SG11202110105UA (en) 2021-10-28
CN113811615A (zh) 2021-12-17
TW202102669A (zh) 2021-01-16
TWI881970B (zh) 2025-05-01
KR102976749B1 (ko) 2026-06-15
WO2020188021A1 (en) 2020-09-24
KR20210141511A (ko) 2021-11-23
JP2022526497A (ja) 2022-05-25

Similar Documents

Publication Publication Date Title
EP4020699A4 (en) PRODUCTION LINE FOR CELLS WITH INTEGRATED TABS
IL287553A (en) Modified pluripotent cells
ZA202203922B (en) Strains and processes for single cell protein or biomass production
IL290080A (en) Natural killer cell preparation and preparations for immunotherapy and methods for their production
IL287318A (en) Materials and methods for the production of proteins
ZA202006252B (en) Yeast proteins
GB201917046D0 (en) Improved protein production
IL290109A (en) Cells for enhanced immune healing and their uses
EP3858974A4 (en) Cell culture chip
GB201915526D0 (en) Modified cell
IL288654A (en) Automated t cell culture
IL314599A (en) Methods for growing cells
IL293515B1 (en) A micro device for multiple cells
GB201904971D0 (en) Cell
GB202115803D0 (en) Novel proteins
IL286419A (en) Novel selection marker-comprising cell line and uses thereof for protein production
GB201906202D0 (en) Cell
EP3684798A4 (en) CELL CULTURE ADDITIVES AND THEIR USE IN THE INCREASED PRODUCTION OF BIOPROTEINS FROM CELLS
GB201910873D0 (en) Novel uses
GB201803491D0 (en) Novel enzymes
IL289564A (en) Modified cells and related methods
HK40062420A (en) Novel selection marker-comprising cell line and uses thereof for protein production
GB201915803D0 (en) Cell production
GB202017506D0 (en) Novel proteins
GB201913320D0 (en) Novel proteins